Supplementary References from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
three references cited in supplementary data
Preguntar a la IA
Me gusta
Guardar
Compartir
Preguntar a la IA
Me gusta
Guardar
Compartir
Supplementary References from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations | Synapse